N. Shibata et al.
47, 6798–6801; other reactions: z) F. Gosselin, R. A. Britton, J.
Mowat, P. D. OꢁShea, I. W. Davies, Synlett 2007, 2193–2196; aa) H.
Nishiyama, J. Ito, Chem. Commun. 2010, 46, 203–212.
Acknowledgements
This study was financially supported in part by Kakenhi (21390030,
22106515). We are grateful to Central Glass for a gift of ethyl trifluoro-
pyruvate.
[7] S. Ogawa, N. Shibata, J. Inagaki, S. Nakamura, T. Toru, M. Shiro,
Angew. Chem. 2007, 119, 8820–8823; Angew. Chem. Int. Ed. 2007,
46, 8666–8669.
[8] N. Shibata, H. Fujimoto, S. Mizuta, S. Ogawa, Y. Ishiuchi, S. Naka-
mura, T. Toru, Synlett 2006, 3484–3488.
[9] a) N. Shibata, S. Mizuta, H. Kawai, Tetrahedron: Asymmetry 2008,
19, 2633–2644; b) N. Shibata, T. Ishimaru, S. Nakamura, T. Toru, J.
Fluorine Chem. 2007, 128, 469–483.
Keywords: asymmetric synthesis · drug design · fluorine ·
organocatalysts · titanium
[10] a) J. Shi, M. Wang, L. He, K. Zheng, X. Liu, L. Lin, X. Feng, Chem.
Commun. 2009, 4711–4713; b) D. H. Paull, C. J. Abraham, M. T.
Scerba, E. A. Danforth, T. Lectka, Acc. Chem. Res. 2008, 41, 655–
663; c) F. Yang, D. Zhao, J. Lan, P. Xi, L. Yang, S. Xiang, J. You,
Angew. Chem. 2008, 120, 5728–5731; Angew. Chem. Int. Ed. 2008,
47 5646–5649; d) Y.-M. Lin, J. Boucau, Z. Li, V. Casarotto, J. Lin,
A. N. Nguyen, J. Ehrmantraut, Org. Lett. 2007, 9, 567–570; e) J.
Wang, X. Hu, J. Jiang, S. Gou, X. Huang, X. Liu, X. Feng, Angew.
Chem. 2007, 119, 8620–8622; Angew. Chem. Int. Ed. 2007, 46, 8468–
8470; f) F. M. Koch, R. Peters, Angew. Chem. 2007, 119, 2739–2743;
Angew. Chem. Int. Ed. 2007, 46, 2685–2689.
[11] a) N. Sato, M. Jitsuoka, T. Shibata, T. Hirohashi, K. Nonoshita, M.
Moriya, Y. Haga, A. Sakuraba, M. Ando, T. Ohe, H. Iwaasa, A.
Gomori, A. Ishihara, A. Kanatani, T. Fukami, J. Med. Chem. 2008,
51, 4765–4770; b) M. Pal, S. Pillarisetti, Cardiovasc. Hematol.
Agents Med. Chem. 2007, 5, 55–66; c) H. Paulsena, C. Schmeck, A.
Brandes, G. Schmidt, J. Stoltefuss, S. N. Wirtz, M. Loegers, P. Naab,
K.-D. Bremm, H. Bischoff, D. Schmidt, S. Zaiss, S. Antons, Chimia
2004, 58, 123–127; d) J. A. Sikorski, D. T. Connolly, Curr. Opin.
Drug Discov. Devel. 2001, 4, 602–613; e) H. Paulsen, S. Antons, A.
Brandes, M. Lçgers, S. N. Mꢄller, P. Naab, C. Schmeck, S. Schneider,
J. Stoltefuꢅ, Angew. Chem. 1999, 111, 3574–3576; Angew. Chem.
Int. Ed. 1999, 38, 3373–3375.
[1] S. Eguchi, Bioactive Heterocycles I, Springer, Heidelberg, 2006.
[2] a) K. Kirk, J. Fluorine Chem. 2006, 127, 1013–1029; b) F. M. D.
Ismail, J. Fluorine Chem. 2002, 118, 27–33; c) G. F. Georgii in Ad-
vances in Heterocyclic Chemistry, Vol. 86 (Ed.: A. R. Katritzky),
Elsevier, Amsterdam, 2004, pp. 129–224.
[3] a) D. B. Harper, D. OꢁHagan, Nat. Prod. Rep. 1994, 11, 123–133;
b) D. OꢁHagan, D. B. Harper, J. Fluorine Chem. 1999, 100, 127–133.
[4] a) E. Franccotte, W. Lindner, Chirality in Drug Research, Wiley-
VCH, Weinheim, 2006; b) I. K. Reddy, R. Mehvar, Chirality in Drug
Design and Development, Marcel Dekker, New York, 2004; c) C. A.
Challener, Chiral Intermediates and Chiral Drugs, Ashgate, Brook-
field, 2001; d) S. T. Stinson, Chem. Eng. News 1995, 44–74.
[5] a) I. Ojima, Fluorine in Medicinal Chemistry and Chemical Biology,
Blackwell, Oxford, 2009; b) S. Purser, P. R. Moore, S. Swallow, V.
Gouverneur, Chem. Soc. Rev. 2008, 37, 320–330; c) C. Isanbor, D.
OꢁHagan, J. Fluorine Chem. 2006, 127, 303–319; d) J.-P. Bꢂguꢂ, D.
Bonnet, J. Fluorine Chem. 2006, 127, 992–1012.
[6] For enantioselective reactions using trifluoropyruvates: aldol reac-
tions see; a) S. M. Landge, B. Tçrçk, Catal. Lett. 2009, 131, 432–
439; b) M. Frings, I. Atodiresei, J. Runsink, G. Raabe, C. Bolm,
Chem. Eur. J. 2009, 15, 1566–1569; c) K. Mikami, Y. Kawakami, K.
Akiyama, K. Aikawa, J. Am. Chem. Soc. 2007, 129, 12950–12951;
d) J. T. Suri, S. Mitsumori, K. Albertshofer, F. Tanaka, C. F. Bar-
[12] CCDC-767825 (4) and 767826 (7) contain the supplementary crystal-
lographic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
[13] A. Terajima, Y. Fukuda, Y. Oomori, JP 08034786.
[14] Y. Tamura, M. Terashima, Y. Higuchi, K. Ozaki, Chem. Ind. 1970,
1435.
ACHTUNGTRENNUNGbas III, J. Org. Chem. 2006, 71, 3822–3828; e) D.-M. Du, S.-F. Lu, T.
Fang, J. Xu, J. Org. Chem. 2005, 70, 3712–3715; f) N. Gathergood,
K. Juhl, T. B. Poulsen, K. Thordrup, K. A. Jørgensen, Org. Biomol.
Chem. 2004, 2, 1077–1085; g) A. Bogevig, N. Kumaragurubaran, K.-
A. Jørgensen, Chem. Commun. 2002, 620–621; Friedel–Crafts reac-
tions: h) J. Nie, G.-W. Zhang, L. Wang, D.-H. Zheng, Y. Zheng, J.-A.
Ma, Eur. J. Org. Chem. 2009, 3145–3149; i) S. Nakamura, K. Hyodo,
Y. Nakamura, N. Shibata, T. Toru, Adv. Synth. Catal. 2008, 350,
1443–1448; j) J.-L. Zhao, L. Liu, C.-L. Gu, D. Wang, Y.-J. Chen, Tet-
rahedron Lett. 2008, 49, 1476–1479; k) H.-M. Dong, H.-H. Lu, L.-Q.
Lu, C.-B. Chen, W.-J. Xiao, Adv. Synth. Catal. 2007, 349, 1597–1603;
l) B. Tçrçk, M. Abid, G. London, J. Esquibel, M. Tçrçk, S. C.
Mhadgut, P. Yan, G. K. S. Prakash, Angew. Chem. 2005, 117, 3146–
3149; Angew. Chem. Int. Ed. 2005, 44, 3086–3089; m) N. Gather-
good, W. Zhuang, K.-A. Jørgensen, J. Am. Chem. Soc. 2000, 122,
12517–12522; n) W. Zhuang, N. Gathergood, R. G. Hazell, K.-A.
Jørgensen, J. Org. Chem. 2001, 66, 1009–1013; o) W. Zhuang, T. B.
Poulsen, K.-A. Jørgensen, Org. Biomol. Chem. 2005, 3, 3284–3289;
p) M. P. A. Lyle, N. D. Draper, P. D. Wilson, Org. Lett. 2005, 7, 901–
904; q) J.-L. Zhao, L. Liu, Y. Sui, Y.-L. Liu, D. Wang, Y.-J. Chen,
Org. Lett. 2006, 8, 6127–6130; r) A. Corma, H. Garcꢃa, A. Moussaif,
M. J. Sabater, R. Zniber, A. Redouane, Chem. Commun. 2002,
1058–1059; ene-reactions; s) K. Aikawa, S. Kainuma, M. Hatano, K.
Mikami, Tetrahedron Lett. 2004, 45, 183–185; t) K. Mikami, K.
Aikawa, S. Kainuma, Y. Kawakami, T. Saito, N. Sayo, H. Kumo-
bayashi, Tetrahedron: Asymmetry 2004, 15, 3885–3889; u) S. Doher-
ty, J. G. Knight, C. H. Smyth, R. W. Harrington, W. Clegg, Organo-
metallics 2007, 26, 5961–5996; v) K. Mikami, H. Kakuno, K.
Aikawa, Angew. Chem. 2005, 117, 7423–7426; Angew. Chem. Int.
Ed. 2005, 44, 7257–7260; w) S. Doherty, J. G. Knight, C. H. Smyth,
R. W. Harrington, W. Clegg, Org. Lett. 2007, 9, 4925–4928; x) J.-F.
Zhao, T.-B. W. Tjan, B.-H. Tan, T.-P. Loh, Org. Lett. 2009, 11, 5714–
5716; y) M. Rueping, T. Theissmann, A. Kuenkel, R. M. Koenigs,
Angew. Chem. 2008, 120, 6903–6906; Angew. Chem. Int. Ed. 2008,
[15] a) M. M. Bastos, L. M. U. Mayer, E. C. S. Figueira, M. Soares, W. B.
Kover, N. Boechat, J. Heterocycl. Chem. 2008, 45, 969–973; b) N.
Boechat, W. B. Kover, M. M. Bastos, N. C. Romeiro, A. S. C. Silva,
F. C. Santos, A. L. Valverde, M. L. G. Azevedo, W. Wollinger,
T. M. L. Souza, S. L. O. de Souza, I. C. P. P. de Frugulhetti, Med.
Chem. Res. 2007, 15, 492–510; c) J. Singh, M. Gurney, G. Hategan,
P. Yu, D. Zembower, N. Zhou, A. Polozov, W. Zeller, WO
2006044415; d) H. A. Schenck, P. W. Lenkowski, I. Choudhury-M. ,
S.-H. Ko, J. P. Stables, M. K. Patel, M. L. Brown, Bioorg. Med.
Chem. 2004, 12, 979–993; e) I. Choudhury-Mukherjee, H. A.
Schenck, S. Cechova, T. N. Pajewski, J. Kapur, J. Ellena, D. S.
Cafiso, M. L. Brown, J. Med. Chem. 2003, 46, 2494–2501.
[16] a) I. Coldham, B. C. Dobson, S. R. Fletcher, A. I. Frankli, Eur. J.
Org. Chem. 2007, 2676–2686; b) T. Flꢆriꢇn, K. Gyçrgy, G. Istvꢇn,
K.-P. Mꢇria, G. ꢈgnes, H. Lꢇszlꢆ, S. Csaba, Heterocycles 2007, 71,
865–880; c) J. Bonjoch, J. Catena, D. Terricabras, J.-C. Fernandez,
M. L. -Canet, N. Valls, Tetrahedron: Asymmetry 1997, 8, 3143–3151;
d) B. Josep, C. Juanlo, V. Nativitat, J. Org. Chem. 1996, 61, 7106–
7115.
[17] a) G. R. Humphrey, J. T. Kuethe, Chem. Rev. 2006, 106, 2875–2911;
b) Y. Murakami, J. Pharm. Soc. Jpn. 1999, 119, 35–60; c) B. Robin-
son, The Fischer Indole Synthesis, Wiley, New York, 1982.
[18] a) R. Iyengar, K. Schildknegt, M. Morton, J. Aube, J. Org. Chem.
2005, 70, 10645–10652; b) D. Gnecco, E. Vꢇzquez, A. Galindo, J. L.
Terꢇn, L. Orea, S. Bernꢉs, R. G. Enrꢃquez, ARKIVOC 2003, xi, 185–
192; c) S. Jegham, J.-L. Fourrey, B. C. Das, Tetrahedron Lett. 1989,
30, 1959–1962.
7094
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 7090 – 7095